Table 2 Baseline demographic and clinical characteristics of 111 bariatric surgery patients with MASLD according to postoperative MASLD status.

From: The early impact of bariatric surgery on metabolic dysfunction-associated steatotic liver disease (MASLD) as assessed by fibroscan at 6 months postoperatively

Number (%)

Persistence of MASLD

Regression of MASLD

p value

68 (61)

43 (39)

-

Female (%)

46 (67)

33 (77)

0.475**

Age ± SD

47.6 ± 10.8

48.3 ± 13.3

0.810***

TWL% ± SD

26 ± 5.3

30 ± 8.3

0.031****

HTN (%)

30 (44)

18 (42)

0.826**

T2DM (%)

15 (22)

9 (21)

1.000*

OSA (%)

33 (49)

29 (67)

0.076**

  1. Data are presented as frequency (%) or mean (SD)
  2. TWL% Total weight loss percentage; HTN hypertension; T2DM type 2 diabetes mellitus; OSA obstructive sleep apnoea
  3. *Fisher’s exact test. ** Chi-square test ***Independent t-test **** Mann-Whitney U test
Back to article page